Contact Us
Sterile Compounding Pharmacies Global Market Report 2025
Global Sterile Compounding Pharmacies Market Report 2025

Report Price : $4490.00

Pages :

Format : PDF

Published : December 2025

Delivery Time : 2-3 Business Days

Purchase This Report Download Sample PDF
Purchase This Report

Sterile Compounding Pharmacies Global Market Report 2025

By Product (Injectables, Nasal, Ocular, Otic), By Therapeutic Area (Hormone Replacement Therapy, Pain Management, Dermatology, Oncology, Hematology, Dental, Other Therapeutic Areas), By Route of Administrations (Intravenous, Intramuscular, Subcutaneous), By End-Users (Adults, Pediatrics, Geriatrics, Veterinary) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Sterile Compounding Pharmacies Market Overview

• Sterile Compounding Pharmacies market size has reached to $5.34 billion in 2024

• Expected to grow to $7.26 billion in 2029 at a compound annual growth rate (CAGR) of 6.6%

• Growth Driver: Surging Demand For Personalized Medicine Drives Growth In Sterile Compounding Pharmacies Market

• Market Trend: Robotic Automation Spurs Efficiency And Safety In Sterile Compounding Pharmacies

North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Sterile Compounding Pharmacies Market?

Sterile compounding pharmacies are specialized pharmacies that prepare customized medications in a sterile environment to offer tailored medication to individuals to their specific needs. This can be beneficial to people for several reasons such as patient intolerance to a particular commercial dose or an intolerance to a specific constituent. This compounding allows patients to get drugs with customized doses and formulations that eliminate non-essential and undesirable components.

The main products in sterile compounding pharmacies are injectables, Nasal, ocular, and otic. Injectables are pharmacological formulations or drugs that may be injected into the body with the use of a needle and a syringe, these sterile compounding pharmacies offer different production services such as customization, patient-specific dose, and tolerance elimination, ensuring the safety, sterility, and quality of injectable medications matched to patients' requirements. These are used in various therapeutic areas such as hormone replacement therapy, pain management, Dermatology, oncology, hematology, dental, and others. These are administered intravenously, intramuscularly, and subcutaneously and are used by various end-users such as adults, pediatrics, geriatrics, and veterinarians.

Sterile Compounding Pharmacies Market Size and growth rate 2025 to 2029: Graph

What Is The Sterile Compounding Pharmacies Market Size 2025 And Growth Rate?

The sterile compounding pharmacies market size has grown strongly in recent years. It will grow from $5.34 billion in 2024 to $5.62 billion in 2025 at a compound annual growth rate (CAGR) of 5.2%. The growth in the historic period can be attributed to patient safety concerns, a shift towards personalized medicine, home infusion therapies, clinical trials and investigational drugs, and support for rare diseases

What Is The Sterile Compounding Pharmacies Market Growth Forecast?

The sterile compounding pharmacies market size is expected to see strong growth in the next few years. It will grow to $7.26 billion in 2029 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to a rise in chronic diseases, aging population and healthcare needs, drug shortages and supply chain disruptions, advancements in precision medicine, increased focus on patient-centric care. Major trends in the forecast period include automation and robotics integration, stringent regulatory compliance, personalized medicine and specialized compounds, shift to outsourced compounding services, and technological advances in aseptic techniques.

The forecast of 6.6% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. specialty pharmacies by driving up the cost of isolator workstations and sterile vial-filling machines sourced from Italy and the Netherlands, exacerbating 503B facility operational costs and limiting customized medication access. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Sterile Compounding Pharmacies Market Segmented?

1) By Product: Injectables, Nasal, Ocular, Otic

2) By Therapeutic Area: Hormone Replacement Therapy, Pain Management, Dermatology, Oncology, Hematology, Dental, Other Therapeutic Areas

3) By Route Of Administrations: Intravenous, Intramuscular, Subcutaneous

4) By End-Users: Adults, Pediatrics, Geriatrics, Veterinary

Subsegments:

1) By Injectables: Sterile Solutions, Sterile Suspensions, Sterile Powders For Reconstitution

2) By Nasal: Nasal Sprays, Nasal Solutions, Nasal Gels

3) By Ocular: Ophthalmic Solutions, Ophthalmic Suspensions, Ocular Inserts

4) By Otic: Otic Solutions, Otic Suspensions, Otic Gels

What Is Driving The Sterile Compounding Pharmacies Market? Surging Demand For Personalized Medicine Drives Growth In Sterile Compounding Pharmacies Market

Increasing demand for personalized medicine is expected to propel the growth of the sterile compounding pharmacies market going forward. Personalized medicine is a type of medicine that prevents, diagnoses, or treats disease by using information about a person's genes or proteins. Sterile compounding pharmacies play a significant role in offering personalized medications to patients in a sterile environment to provide customized medication to people based on their needs and avoid the possibility of intolerance to certain doses or drug compounds. This improves treatment results and increase patient satisfaction and adherence to therapy. For instance, in 2022, according to the report published by Personalized Medicine Coalition, a US-based company operating in personalized medicine services, personalized medicines have now accounted for at least a quarter of new medication approvals, with the approval of 12 new personalized medicines in 2022 which has increased DRAMatically. Therefore, the increasing demand for personalized medicine is driving the sterile compounding pharmacies industry.

What Is Driving The Sterile Compounding Pharmacies Market? Rising Aging Population Fueling Growth In Sterile Compounding Pharmacies Market

The growing aging population is significantly contributing to the growth of the sterile compounding pharmacies market going forward. An aging population refers to a situation where the proportion of older individuals within a society increases over time. Sterile compounding pharmacies play a crucial role in providing customized medication solutions for the aging population, by preparing medications in liquid, topical, or suppository forms, making them easier to take. For instance, in October 2022, according to the World Health Organization, a US-based specialized health agency, globally, 1 in 6 people will be 60 or older by 2030, and there will be a double amount of individuals in this age group (2.1 billion) by 2050. Therefore, the growing aging population will drive the sterile compounding pharmacies industry.

Who Are The Major Players In The Global Sterile Compounding Pharmacies Market?

Major companies operating in the sterile compounding pharmacies market include B. Braun SE, PharMerica Corporation, Fagron Group BV, QuVa Pharma Inc., NewCo Pharma GmbH, Medisca, PharMEDium Healthcare Holdings Inc., Central Admixture Pharmacy Services (CAPS), SandsRx LLC, LeeSar Inc., Avella Specialty Pharmacy, Stokes Pharmacy Inc., Imprimis Pharmaceuticals Inc., Wells Pharmacy Network LLC, McGuff Compounding Pharmacy Services Inc., Potter's House Apothecary Inc., Pharos Innovations LLC, Triangle Compounding Pharmacy Inc., Valor Compounding Pharmacy Inc., Pace Pharmacy, PenCol Specialty Pharmacy LLC, Pavilion Compounding Pharmacy LLC, Olympia Pharmacy, MedisourceRx, Stat RX Pharmacy, Rx3 Compounding Pharmacy, Atlas Pharmaceuticals Co. Ltd., ReNue Rx, Premier Pharmacy Labs Inc., Absolute Pharmacy Inc.

What Are The Key Trends Of The Global Sterile Compounding Pharmacies Market? Robotic Automation Spurs Efficiency And Safety In Sterile Compounding Pharmacies

The adoption of robotic automation is a key trend gaining popularity in the sterile compounding pharmacies market. Major companies operating in the sterile compounding pharmacies market are focused on robotic automation to strengthen their position in the market. For instance, in March 2023, Omnicell Inc., a US-based healthcare technology company, introduced IVX Station, a robotic compounding technology for safe and efficient sterile compounding preparations using automation. The IVX Station features an automated compounding process in an ISO Class 5 environment, as well as temperature, humidity, and particle monitoring continually. It was also designed with safety in mind, with advanced vision systems, gravimetric verification, auto-labeling, and automated application of tamper-evident syringe caps. Furthermore, this new technology allows for scalability with a cloud-based formulation library, which is constantly updated to guarantee manufacturers access to the most recent authorized formulations.

What Are The Key Trends Of The Global Sterile Compounding Pharmacies Market? Strategic Acquisitions For Expansion Of Sterile Compounding Pharmacies Market

Major companies operating in the sterile compounding pharmacies market are focused on adopting strategic acquisition and collaboration to expand their market presence and gain a competitive edge in the market. A strategic acquisition is a corporate transaction where one company purchases another company or its assets, with the primary goal of achieving long-term strategic objectives. For instance, in October 2023, Sharp, a US-based pharmaceutical packaging company acquired Berkshire Sterile Manufacturing (BSM) for an undisclosed amount. The acquisition allows the company to offer fully integrated small-to-medium-scale sterile injectable services. Sharp's services will be complemented by BSM's sterile manufacturing expertise and CDMO services.

Need data on a specific region in this market?

Sterile Compounding Pharmacies Market Merger And Acquisition: Revelation Pharma Corp Expands National Network With Acquisition Of Innovation Compounding Inc

In January 2022, Revelation Pharma Corp, a US-based company operating in compounding pharmacies that offer innovative and high-quality medicinal items, acquired Innovation Compounding Inc. for an undisclosed amount. The acquisition of Innovation reflects Revelation's ongoing goal to build a national network of 503A and 503B compounding pharmacies. Innovation Compounding Inc. is a US-based 503A compounding pharmacy that provides patients in 49 states with sterile and non-sterile compounded pharmaceuticals.

Regional Outlook For The Global Sterile Compounding Pharmacies Market

North America was the dominant region in the sterile compounding pharmacies market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Sterile Compounding Pharmacies Market?

The sterile compounding pharmacies market consists of sales of injectable drugs and infusions created in an environment free from microorganisms. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Sterile Compounding Pharmacies Industry?

The sterile compounding pharmacies market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the sterile compounding pharmacies industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Sterile Compounding Pharmacies Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $5.62 billion
Revenue Forecast In 2034 $7.26 billion
Growth Rate CAGR of 6.6% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Product: Injectables, Nasal, Ocular, Otic
2) By Therapeutic Area: Hormone Replacement Therapy, Pain Management, Dermatology, Oncology, Hematology, Dental, Other Therapeutic Areas
3) By Route Of Administrations: Intravenous, Intramuscular, Subcutaneous
4) By End-Users: Adults, Pediatrics, Geriatrics, Veterinary Subsegments: 1) By Injectables: Sterile Solutions, Sterile Suspensions, Sterile Powders For Reconstitution
2) By Nasal: Nasal Sprays, Nasal Solutions, Nasal Gels
3) By Ocular: Ophthalmic Solutions, Ophthalmic Suspensions, Ocular Inserts
4) By Otic: Otic Solutions, Otic Suspensions, Otic Gels
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled B. Braun SE, PharMerica Corporation, Fagron Group BV, QuVa Pharma Inc., NewCo Pharma GmbH, Medisca, PharMEDium Healthcare Holdings Inc., Central Admixture Pharmacy Services (CAPS), SandsRx LLC, LeeSar Inc., Avella Specialty Pharmacy, Stokes Pharmacy Inc., Imprimis Pharmaceuticals Inc., Wells Pharmacy Network LLC, McGuff Compounding Pharmacy Services Inc., Potter's House Apothecary Inc., Pharos Innovations LLC, Triangle Compounding Pharmacy Inc., Valor Compounding Pharmacy Inc., Pace Pharmacy, PenCol Specialty Pharmacy LLC, Pavilion Compounding Pharmacy LLC, Olympia Pharmacy, MedisourceRx, Stat RX Pharmacy, Rx3 Compounding Pharmacy, Atlas Pharmaceuticals Co. Ltd., ReNue Rx, Premier Pharmacy Labs Inc., Absolute Pharmacy Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Sterile Compounding Pharmacies Market Characteristics

3. Sterile Compounding Pharmacies Market Trends And Strategies

4. Sterile Compounding Pharmacies Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Sterile Compounding Pharmacies Growth Analysis And Strategic Analysis Framework

5.1. Global Sterile Compounding Pharmacies PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Sterile Compounding Pharmacies Market Growth Rate Analysis

5.4. Global Sterile Compounding Pharmacies Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Sterile Compounding Pharmacies Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Sterile Compounding Pharmacies Total Addressable Market (TAM)

6. Sterile Compounding Pharmacies Market Segmentation

6.1. Global Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Injectables

Nasal

Ocular

Otic

6.2. Global Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hormone Replacement Therapy

Pain Management

Dermatology

Oncology

Hematology

Dental

Other Therapeutic Areas

6.3. Global Sterile Compounding Pharmacies Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Intravenous

Intramuscular

Subcutaneous

6.4. Global Sterile Compounding Pharmacies Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Adults

Pediatrics

Geriatrics

Veterinary

6.5. Global Sterile Compounding Pharmacies Market, Sub-Segmentation Of Injectables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Sterile Solutions

Sterile Suspensions

Sterile Powders For Reconstitution

6.6. Global Sterile Compounding Pharmacies Market, Sub-Segmentation Of Nasal, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Nasal Sprays

Nasal Solutions

Nasal Gels

6.7. Global Sterile Compounding Pharmacies Market, Sub-Segmentation Of Ocular, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Ophthalmic Solutions

Ophthalmic Suspensions

Ocular Inserts

6.8. Global Sterile Compounding Pharmacies Market, Sub-Segmentation Of Otic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Otic Solutions

Otic Suspensions

Otic Gels

7. Sterile Compounding Pharmacies Market Regional And Country Analysis

7.1. Global Sterile Compounding Pharmacies Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Sterile Compounding Pharmacies Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Sterile Compounding Pharmacies Market

8.1. Asia-Pacific Sterile Compounding Pharmacies Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Sterile Compounding Pharmacies Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Sterile Compounding Pharmacies Market

9.1. China Sterile Compounding Pharmacies Market Overview

9.2. China Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Sterile Compounding Pharmacies Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Sterile Compounding Pharmacies Market

10.1. India Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Sterile Compounding Pharmacies Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Sterile Compounding Pharmacies Market

11.1. Japan Sterile Compounding Pharmacies Market Overview

11.2. Japan Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Sterile Compounding Pharmacies Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Sterile Compounding Pharmacies Market

12.1. Australia Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Sterile Compounding Pharmacies Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Sterile Compounding Pharmacies Market

13.1. Indonesia Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Sterile Compounding Pharmacies Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Sterile Compounding Pharmacies Market

14.1. South Korea Sterile Compounding Pharmacies Market Overview

14.2. South Korea Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Sterile Compounding Pharmacies Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Sterile Compounding Pharmacies Market

15.1. Western Europe Sterile Compounding Pharmacies Market Overview

15.2. Western Europe Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Sterile Compounding Pharmacies Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Sterile Compounding Pharmacies Market

16.1. UK Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Sterile Compounding Pharmacies Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Sterile Compounding Pharmacies Market

17.1. Germany Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Sterile Compounding Pharmacies Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Sterile Compounding Pharmacies Market

18.1. France Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Sterile Compounding Pharmacies Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Sterile Compounding Pharmacies Market

19.1. Italy Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Sterile Compounding Pharmacies Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Sterile Compounding Pharmacies Market

20.1. Spain Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Sterile Compounding Pharmacies Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Sterile Compounding Pharmacies Market

21.1. Eastern Europe Sterile Compounding Pharmacies Market Overview

21.2. Eastern Europe Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Sterile Compounding Pharmacies Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Sterile Compounding Pharmacies Market

22.1. Russia Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Sterile Compounding Pharmacies Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Sterile Compounding Pharmacies Market

23.1. North America Sterile Compounding Pharmacies Market Overview

23.2. North America Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Sterile Compounding Pharmacies Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Sterile Compounding Pharmacies Market

24.1. USA Sterile Compounding Pharmacies Market Overview

24.2. USA Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Sterile Compounding Pharmacies Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Sterile Compounding Pharmacies Market

25.1. Canada Sterile Compounding Pharmacies Market Overview

25.2. Canada Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Sterile Compounding Pharmacies Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Sterile Compounding Pharmacies Market

26.1. South America Sterile Compounding Pharmacies Market Overview

26.2. South America Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Sterile Compounding Pharmacies Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Sterile Compounding Pharmacies Market

27.1. Brazil Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Sterile Compounding Pharmacies Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Sterile Compounding Pharmacies Market

28.1. Middle East Sterile Compounding Pharmacies Market Overview

28.2. Middle East Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Sterile Compounding Pharmacies Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Sterile Compounding Pharmacies Market

29.1. Africa Sterile Compounding Pharmacies Market Overview

29.2. Africa Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Sterile Compounding Pharmacies Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Sterile Compounding Pharmacies Market Competitive Landscape And Company Profiles

30.1. Sterile Compounding Pharmacies Market Competitive Landscape

30.2. Sterile Compounding Pharmacies Market Company Profiles

30.2.1. B. Braun SE Overview, Products and Services, Strategy and Financial Analysis

30.2.2. PharMerica Corporation Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Fagron Group BV Overview, Products and Services, Strategy and Financial Analysis

30.2.4. QuVa Pharma Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. NewCo Pharma GmbH Overview, Products and Services, Strategy and Financial Analysis

31. Sterile Compounding Pharmacies Market Other Major And Innovative Companies

31.1. Medisca

31.2. PharMEDium Healthcare Holdings Inc.

31.3. Central Admixture Pharmacy Services (CAPS)

31.4. SandsRx LLC

31.5. LeeSar Inc.

31.6. Avella Specialty Pharmacy

31.7. Stokes Pharmacy Inc.

31.8. Imprimis Pharmaceuticals Inc.

31.9. Wells Pharmacy Network LLC

31.10. McGuff Compounding Pharmacy Services Inc.

31.11. Potter's House Apothecary Inc.

31.12. Pharos Innovations LLC

31.13. Triangle Compounding Pharmacy Inc.

31.14. Valor Compounding Pharmacy Inc.

31.15. Pace Pharmacy

32. Global Sterile Compounding Pharmacies Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Sterile Compounding Pharmacies Market

34. Recent Developments In The Sterile Compounding Pharmacies Market

35. Sterile Compounding Pharmacies Market High Potential Countries, Segments and Strategies

35.1 Sterile Compounding Pharmacies Market In 2029 - Countries Offering Most New Opportunities

35.2 Sterile Compounding Pharmacies Market In 2029 - Segments Offering Most New Opportunities

35.3 Sterile Compounding Pharmacies Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Sterile Compounding Pharmacies Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Sterile Compounding Pharmacies Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Sterile Compounding Pharmacies Market, Sub-Segmentation Of Injectables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Sterile Compounding Pharmacies Market, Sub-Segmentation Of Nasal, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Sterile Compounding Pharmacies Market, Sub-Segmentation Of Ocular, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Sterile Compounding Pharmacies Market, Sub-Segmentation Of Otic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Sterile Compounding Pharmacies Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Sterile Compounding Pharmacies Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, Sterile Compounding Pharmacies Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, Sterile Compounding Pharmacies Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, Sterile Compounding Pharmacies Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, Sterile Compounding Pharmacies Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, Sterile Compounding Pharmacies Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, Sterile Compounding Pharmacies Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, Sterile Compounding Pharmacies Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, Sterile Compounding Pharmacies Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, Sterile Compounding Pharmacies Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, Sterile Compounding Pharmacies Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, Sterile Compounding Pharmacies Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, Sterile Compounding Pharmacies Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, Sterile Compounding Pharmacies Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, Sterile Compounding Pharmacies Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, Sterile Compounding Pharmacies Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, Sterile Compounding Pharmacies Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, Sterile Compounding Pharmacies Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, Sterile Compounding Pharmacies Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, Sterile Compounding Pharmacies Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, Sterile Compounding Pharmacies Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, Sterile Compounding Pharmacies Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, Sterile Compounding Pharmacies Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: B. Braun SE Financial Performance
  • Table 80: PharMerica Corporation Financial Performance
  • Table 81: Fagron Group BV Financial Performance
  • Table 82: QuVa Pharma Inc. Financial Performance
  • Table 83: NewCo Pharma GmbH Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Sterile Compounding Pharmacies Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Sterile Compounding Pharmacies Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Sterile Compounding Pharmacies Market, Sub-Segmentation Of Injectables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Sterile Compounding Pharmacies Market, Sub-Segmentation Of Nasal, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Sterile Compounding Pharmacies Market, Sub-Segmentation Of Ocular, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Sterile Compounding Pharmacies Market, Sub-Segmentation Of Otic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Sterile Compounding Pharmacies Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Sterile Compounding Pharmacies Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, Sterile Compounding Pharmacies Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, Sterile Compounding Pharmacies Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, Sterile Compounding Pharmacies Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, Sterile Compounding Pharmacies Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, Sterile Compounding Pharmacies Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, Sterile Compounding Pharmacies Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, Sterile Compounding Pharmacies Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, Sterile Compounding Pharmacies Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, Sterile Compounding Pharmacies Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, Sterile Compounding Pharmacies Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, Sterile Compounding Pharmacies Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, Sterile Compounding Pharmacies Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, Sterile Compounding Pharmacies Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, Sterile Compounding Pharmacies Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, Sterile Compounding Pharmacies Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, Sterile Compounding Pharmacies Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, Sterile Compounding Pharmacies Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, Sterile Compounding Pharmacies Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, Sterile Compounding Pharmacies Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, Sterile Compounding Pharmacies Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, Sterile Compounding Pharmacies Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, Sterile Compounding Pharmacies Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: B. Braun SE Financial Performance
  • Figure 80: PharMerica Corporation Financial Performance
  • Figure 81: Fagron Group BV Financial Performance
  • Figure 82: QuVa Pharma Inc. Financial Performance
  • Figure 83: NewCo Pharma GmbH Financial Performance

Frequently Asked Questions

Sterile compounding pharmacies are specialized pharmacies that prepare customized medications in a sterile environment to offer tailored medication to individuals to their specific needs. This can be beneficial to people for several reasons such as patient intolerance to a particular commercial dose or an intolerance to a specific constituent. This compounding allows patients to get drugs with customized doses and formulations that eliminate non-essential and undesirable components. For further insights on this market, request a sample here

The market major growth driver - Surging Demand For Personalized Medicine Drives Growth In Sterile Compounding Pharmacies Market. For further insights on this market, request a sample here

The sterile compounding pharmacies market size has grown strongly in recent years. It will grow from $5.34 billion in 2024 to $5.62 billion in 2025 at a compound annual growth rate (CAGR) of 5.2%. The growth in the historic period can be attributed to patient safety concerns, a shift towards personalized medicine, home infusion therapies, clinical trials and investigational drugs, and support for rare diseases. The sterile compounding pharmacies market size is expected to see strong growth in the next few years. It will grow to " $7.26 billion in 2029 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to a rise in chronic diseases, aging population and healthcare needs, drug shortages and supply chain disruptions, advancements in precision medicine, increased focus on patient-centric care. Major trends in the forecast period include automation and robotics integration, stringent regulatory compliance, personalized medicine and specialized compounds, shift to outsourced compounding services, and technological advances in aseptic techniques. For further insights on this market, request a sample here

The sterile compounding pharmaciesmarket covered in this report is segmented –
1) By Product: Injectables; Nasal; Ocular; Otic
2) By Therapeutic Area: Hormone Replacement Therapy; Pain Management; Dermatology; Oncology; Hematology; Dental; Other Therapeutic Areas
3) By Route Of Administrations: Intravenous; Intramuscular; Subcutaneous
4) By End-Users: Adults; Pediatrics; Geriatrics; Veterinary Subsegments:
1) By Injectables: Sterile Solutions; Sterile Suspensions; Sterile Powders For Reconstitution
2) By Nasal: Nasal Sprays; Nasal Solutions; Nasal Gels
3) By Ocular: Ophthalmic Solutions; Ophthalmic Suspensions; Ocular Inserts
4) By Otic: Otic Solutions; Otic Suspensions; Otic Gels For further insights on this market,
request a sample here

North America was the dominant region in the sterile compounding pharmacies market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sterile compounding pharmacies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Major companies operating in the sterile compounding pharmacies market include B. Braun SE, PharMerica Corporation, Fagron Group BV, QuVa Pharma Inc., NewCo Pharma GmbH, Medisca, PharMEDium Healthcare Holdings Inc., Central Admixture Pharmacy Services (CAPS), SandsRx LLC, LeeSar Inc., Avella Specialty Pharmacy, Stokes Pharmacy Inc., Imprimis Pharmaceuticals Inc., Wells Pharmacy Network LLC, McGuff Compounding Pharmacy Services Inc., Potter's House Apothecary Inc., Pharos Innovations LLC, Triangle Compounding Pharmacy Inc., Valor Compounding Pharmacy Inc., Pace Pharmacy, PenCol Specialty Pharmacy LLC, Pavilion Compounding Pharmacy LLC, Olympia Pharmacy, MedisourceRx, Stat RX Pharmacy, Rx3 Compounding Pharmacy, Atlas Pharmaceuticals Co. Ltd., ReNue Rx, Premier Pharmacy Labs Inc., Absolute Pharmacy Inc. . For further insights on this market, request a sample here.

Major trends in this market include Robotic Automation Spurs Efficiency And Safety In Sterile Compounding Pharmacies. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Back to top WhatsApp icon